Symbiotic approach to drug design: antihypertensive beta-adrenergic blocking agents.
D000319:Adrenergic beta-Antagonists / Q000138:chemical synthesis*; D000818:Animals; D000959:Antihypertensive Agents / Q000138:chemical synthesis*; D002626:Chemistry, Pharmaceutical; D004285:Dogs; D006973:Hypertension / Q000503:physiopathology; D007093:Imidazoles / Q000138:chemical synthesis / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013329:Structure-Activity Relationship; D014665:Vasodilator Agents / Q000138:chemical synthesis
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D007093:Imidazoles; D014665:Vasodilator Agents